EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transarterial Radioembolization for Management of Hepatocellular Carcinoma

Wali Badar, Qian Yu, Mikin Patel, Osman Ahmed

The Oncologist · 02.02.2024 · 29 (2) · 117-122

DOI: 10.1093/oncolo/oyad327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 21.12.2023. Verfasst von Wali Badar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Embolization, Therapeutic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transarterial radioembolization (TARE) with Yttrium-90 (Y90) is a growing area of study due to its benefits in early-, intermediate-, and late-stage hepatocellular carcinoma. Treatment intent, including curative therapy, bridging to transplant, and downstaging disease, informs treatment approach and dosimetry goals. Radiation lobectomy (RL) and radiation segmentectomy (RS) are the 2 main forms of Y90 administration which have shown improved survival outcomes with the development of personalized dosimetry. RS aims to achieve complete pathological necrosis with dose escalation and RL aims for local disease control as well as induction of contralateral lobe hypertrophy to improve hepatic reserve. Furthermore, TARE has been validated in head-to-head comparison to other locoregional and systemic therapies. Lastly, early potential exists for combination therapy between TARE and immune checkpoint inhibitors for advanced stage disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsEmbolization, TherapeuticHumansYttrium Radioisotopes

Stichwörter der Autor:innen

hepatocellular carcinomaradiationtransarterial radioembolizationyttrium-90

Substanzen

Yttrium-90Yttrium Radioisotopes

Autor:innen und Institutionen

  • Division of Interventional Radiology, Department of Radiology, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA.
  • Division of Interventional Radiology, Department of Radiology, University of Chicago, Chicago, IL, USA.

Zitieren

APA

Badar, W., Yu, Q., Patel, M., & Ahmed, O. (2024). Transarterial Radioembolization for Management of Hepatocellular Carcinoma. The Oncologist, 29(2), 117-122. https://doi.org/10.1093/oncolo/oyad327

Vancouver

Badar W, Yu Q, Patel M, Ahmed O. Transarterial Radioembolization for Management of Hepatocellular Carcinoma. The Oncologist. 2024;29(2):117-122. doi:10.1093/oncolo/oyad327

BibTeX
@article{Badar2024,
  author = {Badar, Wali and Yu, Qian and Patel, Mikin and Ahmed, Osman},
  title = {Transarterial Radioembolization for Management of Hepatocellular Carcinoma},
  journal = {The Oncologist},
  year = {2024},
  volume = {29},
  number = {2},
  pages = {117--122},
  doi = {10.1093/oncolo/oyad327}
}
Kostenlos starten →